4-Morpholin-4-yl-4-oxo-2-phenylmethanesulfonylmethyl-butyric acid | 440125-72-4

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 恶嗪烷类
• 英文名称: 4-Morpholin-4-yl-4-oxo-2-phenylmethanesulfonylmethyl-butyric acid
• 英文别名: 4-Morpholin-4-yl-4-oxo-2-benzylsulfonylmethyl-butyric acid；2-(benzylsulfonylmethyl)-4-morpholin-4-yl-4-oxobutanoic acid
• CAS: 440125-72-4
• 化学式: C₁₆H₂₁NO₆S
• 分子量: 355.412
• InChiKey: CPBAZWIFABLRND-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -0.3
• 重原子数：
  24
• 可旋转键数：
  7
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  109
• 氢给体数：
  1
• 氢受体数：
  6

反应信息

• 作为反应物：
  描述：

  4-Morpholin-4-yl-4-oxo-2-phenylmethanesulfonylmethyl-butyric acid 、 (S)-2-amino-1-(5-trifluoromethyl-1,2,4-oxadiazol-3-yl)-butan-1-ol trifluoroacetate 生成 4-Morpholin-4-yl-4-oxo-2-phenylmethanesulfonylmethyl-N-[(S)-1-(5-trifluoromethyl-1,2,4-oxadiazole-3-carbonyl)-propyl]-butyramide
  参考文献：
  名称：

  Compounds and compositions as cathepsin inhibitors

  摘要：

  本发明涉及新型的S型卡特普西酶抑制剂，其药用盐和N-氧化物，以及它们作为治疗剂的用途和制备方法。

  公开号：

  US07030116B2

文献信息

• Compounds and compositions as cathepsin inhibitors
  申请人：Aventis Pharmaceuticals Inc.

  公开号：US07030116B2

  公开（公告）日：2006-04-18

  The present invention relates to novel cathepsin S inhibitors, the pharmaceutically acceptable salts and N-oxides thereof, their uses as therapeutic agents and the methods of their making.

  本发明涉及新型的S型卡特普西酶抑制剂，其药用盐和N-氧化物，以及它们作为治疗剂的用途和制备方法。
• NOVEL COMPOUNDS AND COMPOSITIONS AS CATHEPSIN INHIBITORS
  申请人：AXYS PHARMACEUTICALS, INC.

  公开号：EP1383748A2

  公开（公告）日：2004-01-28
• US7030116B2
  申请人：——

  公开号：US7030116B2

  公开（公告）日：2006-04-18
• [EN] NOVEL COMPOUNDS AND COMPOSITIONS AS CATHEPSIN INHIBITORS<br/>[FR] COMPOSES ET COMPOSITIONS EN TANT QU'INHIBITEURS DE CATHEPSINE
  申请人：CELERA AN APPLERA CORP BUSINES

  公开号：WO2002051983A2

  公开（公告）日：2002-07-04

  The present invention relates to novel selective cathepsin S inhibitors, the pharmaceutically acceptable salts and N-oxides thereof, their uses as therapeutic agents and the methods of their making
• [EN] MORPHOLINE AND TETRAHYDROPYRAN DRIVATIVES AND THEIR USE AS CATHEPSIN INHIBITORS<br/>[FR] DERIVES DE MORPHOLINE ET DE TETRAHYDROPYRANE ET LEUR UTILISATION EN TANT QU'INHIBITEURS DE CATHEPSINE
  申请人：AVENTIS PHARMA INC

  公开号：WO2004002491A1

  公开（公告）日：2004-01-08

  The present invention relates to novel cathepsin S inhibitors, the pharmaceutically acceptable salts and N-oxides thereof, their uses as therapeutic agents and the methods of their making.